Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Strabag, Marinomed (11/05/2026)

17.05.2026

Strabag: After two years of design-and-build preparation, construction group STRABAG, in partnership with Group company ZÜBLIN, was awarded the contract for the structural implementation of several procurement packages for the project ABS Gäubahn Nord / Pfaffensteigtunnel. The scheme is regarded as one of the key infrastructure schemes in the expansion of the Gäubahn rail line in south-west Germany and plays a decisive role in strengthening climate-friendly, future-oriented mobility. The client is DB Projekt Stuttgart–Ulm GmbH.
Strabag: weekly performance: -2.16%

Marinomed: Marinomed Biotech AG, a healthcare-focused innovator committed to improving patient outcomes, announced that Tacrolimus eyedrops are the prime candidate for entering the compounding business based on input from ophthalmologists worldwide. Marinomed expects first revenues in Q4 2026 or beginning of 2027 from partners and fast growth in 2027. Marinomed has gathered extensive feedback from key opinion leaders worldwide in the field of inflammatory ocular surface disease. The experts confirmed significant unmet medical need for Tacrolimus eyedrops in specific indications and for certain patient populations that cannot be adequately addressed by existing therapies. Compounded Tacrolimus eyedrops based on the Marinosolv technology could close this gap and is also an interesting commercial opportunity.
Marinomed Biotech: weekly performance: -8.26%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (11/05/2026)


Partners









latest 21st Austria

21st Austria weekly - Strabag, Marinomed (11/05/2026)


17.05.2026, 1520 Zeichen



Strabag: After two years of design-and-build preparation, construction group STRABAG, in partnership with Group company ZÜBLIN, was awarded the contract for the structural implementation of several procurement packages for the project ABS Gäubahn Nord / Pfaffensteigtunnel. The scheme is regarded as one of the key infrastructure schemes in the expansion of the Gäubahn rail line in south-west Germany and plays a decisive role in strengthening climate-friendly, future-oriented mobility. The client is DB Projekt Stuttgart–Ulm GmbH.
Strabag: weekly performance: -2.16%

Marinomed: Marinomed Biotech AG, a healthcare-focused innovator committed to improving patient outcomes, announced that Tacrolimus eyedrops are the prime candidate for entering the compounding business based on input from ophthalmologists worldwide. Marinomed expects first revenues in Q4 2026 or beginning of 2027 from partners and fast growth in 2027. Marinomed has gathered extensive feedback from key opinion leaders worldwide in the field of inflammatory ocular surface disease. The experts confirmed significant unmet medical need for Tacrolimus eyedrops in specific indications and for certain patient populations that cannot be adequately addressed by existing therapies. Compounded Tacrolimus eyedrops based on the Marinosolv technology could close this gap and is also an interesting commercial opportunity.
Marinomed Biotech: weekly performance: -8.26%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (11/05/2026)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1162: Pfingstmontag bringt ATX und DAX grosse Aufschläge, AT&S kurz nach Rebalancing schon wieder Top-Gewicht




 

Bildnachweis

Aktien auf dem Radar:AT&S, FACC, Infineon, Vonovia SE, Merck Co., Rosenbauer, EuroTeleSites AG, Semperit, Zumtobel, EVN, Bawag, ATX, ATX Prime, ATX TR, Bajaj Mobility AG, ATX NTR, Porr, Strabag, Austriacard Holdings AG, DO&CO, Erste Group, RBI, SBO, Wienerberger, Wolford, Wolftank-Adisa, BTV AG, BKS Bank Stamm, Athos Immobilien, Josef Manner & Comp. AG, Amag.


Random Partner

BNP Paribas
BNP Paribas ist eine führende europäische Bank mit internationaler Reichweite. Sie ist mit mehr als 190.000 Mitarbeitern in 74 Ländern vertreten, davon über 146.000 in Europa. BNP Paribas ist in vielen Bereichen Marktführer oder besetzt Schlüsselpositionen am Markt und gehört weltweit zu den kapitalstärksten Banken.

>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten